a way of thinking
Today, Fidia is expanding its global reach and successfully distributes its products worldwide, through an established network of international partners operating in the pharmaceutical and biomedical sectors, both on a global and local scale. As a result of a long-standing belief in the value of research and a wise choice of partnerships, Fidia has some considerable achievements to its name.
One example is in the sector of intra-articular joint therapy, in which it is European leader and a key player in the United States with its hyaluronic acid-based products for the treatment of osteoarthritis. As a result, more than 14,000 patients have been involved so far in 110+ clinical trials worldwide, with over 50 million injections administered since launch in 1987.
Fidia's pipeline of products comprises medicinal products, medical devices and nutritional supplements.
The international approach is crucial to the company, whose products are present in over 100 countries worldwide, through a comprehensive network of alliances and distributors, among which are major players in the pharmaceutical market segments in which Fidia operates.
The pharmaceutical segment is extremely crowded, thus optimizing performance in the pharmerging sector will be increasingly important for the company's global success and sustainable competitive edge. Since attractive market dynamics usually mean new market opportunities, Fidia is establishing a direct presence in attractive markets - including the US and Germany - with local business and liaison offices.